Kestra Medical Technologies (KMTS) Profit After Tax (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Profit After Tax data on file, last reported at -$34.2 million in Q1 2026.

• Profit After Tax for Q1 2026 came in at -$34.2 million, down 58.85% year-over-year; the trailing twelve-month figure through Jan 2026 was -$144.8 million (down 72.32% YoY), and the FY2025 annual result was -$113.8 million, down 20.92% from the prior year.
• Profit After Tax eased to -$34.2 million in Q1 2026 per KMTS's latest filing, from -$32.8 million in the prior quarter.
• Over five years, Profit After Tax peaked at -$19.9 million in Q3 2024 and troughed at -$52.1 million in Q2 2025.
• A 3-year average of -$27.8 million and a median of -$22.3 million in 2024 frame the typical range for Profit After Tax.
• On a YoY basis, Profit After Tax climbed as much as 0.51% in 2025 and fell as far as 133.59% in 2025.
• A 3-year view of Profit After Tax shows it stood at -$20.4 million in 2024, then sank by 60.96% to -$32.8 million in 2025, then retreated by 4.21% to -$34.2 million in 2026.
• Business Quant data shows KMTS's Profit After Tax at -$34.2 million in Q1 2026, -$32.8 million in Q4 2025, and -$25.8 million in Q3 2025.